Atazanavir/ritonavir - Mylan Laboratories
Alternative Names: Anzavir-R; Ritonavir/atazanavirLatest Information Update: 21 Sep 2021
At a glance
- Originator Mylan Laboratories Limited
- Class Amides; Antiretrovirals; Carbamates; Oligopeptides; Pyridines; Small molecules; Thiazoles
- Mechanism of Action HIV protease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed HIV infections
Most Recent Events
- 06 Aug 2019 Mylan's Atazanavir/ritonavir is not yet available in USA for HIV infections (PO) (Mylan Laboratories Limited website, August 2019)
- 21 Mar 2017 Mylan's Atazanavir/ritonavir is still tentatively approved for HIV infections in USA (PO)
- 30 Jun 2012 Launched for HIV infections in India (PO)